Is it possible to pitch the full potential of discoveries without spilling the secret sauce?

On October 4, 2018, Posted by , In Press Releases, By , , With Comments Off on Is it possible to pitch the full potential of discoveries without spilling the secret sauce?

Heidelberg, 04.10.2018 On Tuesday October 2, Guenter Huhle, Head of JLABS EMEA, Johnson & Johnson Innovation shared key insights on the art of pitching in front of a packed audience of researchers, entrepreneurs and professionals mainly from the Heidelberg area.   Panel discussion: Maciek Drozdz (Principal of Venture Investments for…

Cutting-edge research and social-economic issues of precision oncology at the first Visionary Seminar in Heidelberg

On September 27, 2018, Posted by , In Press Releases, By , , With Comments Off on Cutting-edge research and social-economic issues of precision oncology at the first Visionary Seminar in Heidelberg

Heidelberg, 27.09.2018 On Tuesday September 25, the first Visionary Seminar in Heidelberg focusing on “Precision Oncology”  attracted around 100 participants to learn and discuss about most recent research advancements and cutting-edge technologies in the field, with a focus on their social-economic impact.   Closing panel discussion: Prof. De Nys (Chair…

EUROoC network lays the foundation for joint European organ-on-a-chip research

On September 17, 2018, Posted by , In News, By , , With Comments Off on EUROoC network lays the foundation for joint European organ-on-a-chip research

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is coordinating the establishment of a European research network to promote organ-on-a-chip technology. This enables the replication of human organs on a micro scale and is considered a technology with great potential, among other things for the research of new pharmaceutical…

Partnering for Innovation at the Heidelberg Science Day

On September 12, 2018, Posted by , In Press Releases, By , With Comments Off on Partnering for Innovation at the Heidelberg Science Day

Heidelberg, 12.09.2018 To foster innovation and to keep providing cutting-edge science and technology, global healthcare companies are more and more closely collaborating with partners all over the world. The BMBF funded ‘Health Axis Europe Partnering’ (HAEP -) project in which BioRN has the project lead works as interface between innovation…

Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager – based Immunotherapeutics for Multiple Cancer Targets

On August 29, 2018, Posted by , In News, By , , With Comments Off on Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager – based Immunotherapeutics for Multiple Cancer Targets

Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales. Affimed will apply its proprietary Redirected Optimized Cell Killing (ROCK®) platform, which enables the generation of both NK cell and T cell-engaging antibodies, to…

Boehringer Ingelheim Championing Early-Stage Life Science Entrepreneur Innovation in Heidelberg

On July 10, 2018, Posted by , In Press Releases, By ,, , With Comments Off on Boehringer Ingelheim Championing Early-Stage Life Science Entrepreneur Innovation in Heidelberg

Heidelberg 10.07.2018 BioRN as cross-cutting representative of the life science community supported Boehringer Ingelheim in the organisation, promotion and execution of this successful event. Open panel discussion during the Summer Networking Reception. Partnerships with early-stage companies often spark some of the most innovative research and development collaborations in the healthcare…

Roche joins EMBL’s Corporate Partnership Programme

On June 12, 2018, Posted by , In News, By ,, , With Comments Off on Roche joins EMBL’s Corporate Partnership Programme

Roche and EMBL join forces to create new training opportunities for young researchers                               EMBL welcomes Roche, a frontrunner in personalised healthcare and leading provider of in vitro diagnostics, to the EMBL Advanced Training Centre Corporate Partnership Programme. The new partners will develop advanced training for young investigators and the…

Heidelberg, Paris, Prague and Warsaw Build European University Alliance

On March 22, 2018, Posted by , In News, By , , With Comments Off on Heidelberg, Paris, Prague and Warsaw Build European University Alliance

Signing of the declaration on the founding of the European University Alliance “4EU“: From left to right, Prof. Dr Marcin Palys (University of Warsaw), Prof. Dr Jean Chambaz (Sorbonne University), Prof. Dr Bernhard Eitel (Heidelberg University) and Vice-President Prof. Dr Lenka Rovná (on behalf of the President of Charles University…

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

On March 20, 2018, Posted by , In News, By ,, , With Comments Off on Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research partnership will focus on the discovery and development of new chemical therapeutics targeting the pro-survival protein MCL1 as a potential therapy against MCL1 dependent cancers. This is the third…

University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

On March 13, 2018, Posted by , In News, By , , With Comments Off on University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

Baden-Württemberg Ministry of Science will support a research bridge between the Ruperto Carola and the Max Planck Institute for Medical Research in Heidelberg, by funding a new building in the life science innovation campus “Heidelberg 4 life”. The funding has been formalized by the Minister of Science, Research and the…